Viewing Study NCT07237256


Ignite Creation Date: 2025-12-24 @ 11:37 PM
Ignite Modification Date: 2026-01-05 @ 8:03 AM
Study NCT ID: NCT07237256
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-11-19
First Post: 2025-11-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib
Sponsor: UNICANCER
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module